In the last trading session, 1.37 million Neuronetics Inc (NASDAQ:STIM) shares changed hands as the company’s beta touched 2.14. With the company’s per share price at $3.45 changed hands at $0.25 or 7.81% during last session, the market valuation stood at $110.64M. STIM’s last price was a discount, traded about -46.96% off its 52-week high of $5.07. The share price had its 52-week low at $0.52, which suggests the last value was 84.93% up since then. When we look at Neuronetics Inc’s average trading volume, we note the 10-day average is 1.07 million shares, with the 3-month average coming to 791.23K.
Analysts gave the Neuronetics Inc (STIM) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.50. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended STIM as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Neuronetics Inc’s EPS for the current quarter is expected to be -0.24.
Neuronetics Inc (NASDAQ:STIM) trade information
Instantly STIM was in green as seen at the end of in last trading. With action 14.62%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 114.29%, with the 5-day performance at 14.62% in the green. However, in the 30-day time frame, Neuronetics Inc (NASDAQ:STIM) is 131.54% up. Looking at the short shares, we see there were 0.74 million shares sold at short interest cover period of 4.05 days.
The consensus price target for the stock as assigned by Wall Street analysts is 8, meaning bulls need an upside of 56.88% from its current market value. According to analyst projections, STIM’s forecast low is 8 with 8 as the target high. To hit the forecast high, the stock’s price needs a -131.88% plunge from its current level, while the stock would need to soar -131.88% for it to hit the projected low.
Neuronetics Inc (STIM) estimates and forecasts
Data shows that the Neuronetics Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 91.67% over the past 6 months, a -21.90% in annual growth rate that is considerably lower than the industry average of 15.10%. Year-over-year growth is forecast to reach 0.01% up from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 18.98M. 1 analysts are of the opinion that Neuronetics Inc’s revenue for the current quarter will be 28.8M. The company’s revenue for the corresponding quarters a year ago was 20.31M and 17.42M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -6.55%. The estimates for the next quarter sales put growth at 65.36%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 17.12%. The 2025 estimates are for Neuronetics Inc earnings to decrease by -20.87%, but the outlook for the next 5-year period is at 26.12% per year.
STIM Dividends
Neuronetics Inc is expected to release its next quarterly earnings report in March.
Neuronetics Inc (NASDAQ:STIM)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 11.10% of Neuronetics Inc shares while 53.32% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 59.98%. There are 53.32% institutions holding the Neuronetics Inc stock share, with ARCHON CAPITAL MANAGEMENT LLC the top institutional holder. As of 2024-06-30, the company held 8.3919% of the shares, roughly 2.47 million STIM shares worth $4.45 million.
CANNELL CAPITAL LLC holds the second largest percentage of outstanding shares, with 8.0799% or 2.38 million shares worth $4.29 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 849.5 shares estimated at $2.93 million under it, the former controlled 2.80% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 1.33% of the shares, roughly 403.88 shares worth around $1.39 million.
